CVE-2022-1517: Illumina Local Run Manager RCE Vulnerability

CVE-2022-1517 Overview

CVE-2022-1517 is a critical privilege escalation vulnerability affecting Illumina Local Run Manager (LRM) software used in DNA sequencing instruments. The vulnerability exists because LRM utilizes elevated privileges, allowing an unauthenticated malicious actor to upload and execute code remotely at the operating system level. This flaw enables attackers to change settings, configurations, software, or access sensitive data on the affected product. An attacker could also exploit this vulnerability to access APIs not intended for general use and interact through the network.

Critical Impact

Unauthenticated remote code execution with operating system-level privileges on critical healthcare and research DNA sequencing equipment, potentially compromising sensitive genomic data and research integrity.

Affected Products

• Illumina Local Run Manager
• Illumina iSeq 100
• Illumina MiniSeq
• Illumina MiSeq
• Illumina MiSeq Dx
• Illumina NextSeq 500
• Illumina NextSeq 550
• Illumina NextSeq 550Dx

Discovery Timeline

• 2022-06-24 - CVE-2022-1517 published to NVD
• 2024-11-21 - Last updated in NVD database

Technical Details for CVE-2022-1517

Vulnerability Analysis

This vulnerability represents a severe security flaw in medical and research equipment used for DNA sequencing. The Illumina Local Run Manager software runs with unnecessarily elevated privileges, creating an opportunity for unauthorized access. The weakness is classified under CWE-250 (Execution with Unnecessary Privileges) and CWE-269 (Improper Privilege Management), indicating fundamental flaws in the security architecture of the software.

The vulnerability allows unauthenticated attackers to interact with the system over the network without any authentication requirements. Once access is gained, the attacker can upload arbitrary code that executes with the elevated privileges of the LRM service. This provides complete control over the affected sequencing instrument, including access to APIs that should be restricted from general use.

Root Cause

The root cause stems from improper privilege management within the Illumina Local Run Manager software. The LRM service operates with elevated operating system privileges that exceed what is necessary for its intended functionality. Combined with insufficient authentication controls, this creates a scenario where remote attackers can leverage these excessive privileges to execute arbitrary code. The design flaw exposes sensitive genomic data and critical sequencing operations to unauthorized access.

Attack Vector

The attack vector is network-based and requires no authentication or user interaction. An attacker with network access to the affected instrument can remotely upload malicious code that executes with the elevated privileges of the LRM service. This could allow the attacker to:

• Modify sequencing configurations and settings
• Access and exfiltrate sensitive genomic data
• Install persistent malware on the system
• Access restricted APIs for deeper system manipulation
• Potentially pivot to other network-connected systems

The attack complexity is low, making exploitation straightforward for attackers who can reach the vulnerable system over the network.

Detection Methods for CVE-2022-1517

Indicators of Compromise

• Unexpected network connections to the LRM service from unauthorized IP addresses
• Unusual file uploads or modifications in the Local Run Manager directories
• Unexpected processes running with elevated privileges on sequencing instruments
• Anomalous API calls to restricted endpoints
• Unauthorized configuration changes on affected Illumina devices

Detection Strategies

• Monitor network traffic to and from Illumina sequencing instruments for anomalous patterns
• Implement network intrusion detection systems (IDS) with signatures for unauthorized LRM API access
• Review system logs on affected instruments for unexpected code execution or privilege escalation events
• Deploy endpoint detection and response (EDR) solutions on systems hosting LRM software

Monitoring Recommendations

• Establish baseline network behavior for Illumina instruments and alert on deviations
• Monitor for unauthorized file uploads or modifications on affected systems
• Implement continuous monitoring for new processes spawned by the LRM service
• Configure alerts for access attempts to restricted APIs

How to Mitigate CVE-2022-1517

Immediate Actions Required

• Isolate affected Illumina instruments from untrusted networks immediately
• Implement network segmentation to restrict access to sequencing equipment
• Apply any available patches or firmware updates from Illumina
• Review the CISA ICS Advisory ICSA-22-153-02 for detailed mitigation guidance

Patch Information

Illumina has been notified of this vulnerability through the disclosure process. Organizations should contact Illumina directly for the latest firmware and software updates that address CVE-2022-1517. Detailed patch information and remediation guidance is available in the CISA ICS Advisory. It is critical to apply vendor-provided updates as soon as they are available, given the severity of this vulnerability.

Workarounds

• Implement strict network segmentation to isolate sequencing instruments from general network traffic
• Deploy firewall rules to restrict network access to affected devices to only authorized systems and users
• Disable or restrict access to unnecessary network services on the affected instruments
• Implement strong access controls and monitoring for any network pathways to the vulnerable systems
• Consider air-gapping critical sequencing equipment if remote access is not operationally required

# Example firewall rules to restrict access to LRM (adapt to your environment)
# Allow access only from trusted management network
iptables -A INPUT -s 10.10.10.0/24 -p tcp --dport 443 -j ACCEPT
iptables -A INPUT -p tcp --dport 443 -j DROP